Pediatrix Medical Group, Inc. MD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.91% | 0.51% | -2.25% | -4.92% | -4.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.91% | 0.51% | -2.25% | -4.92% | -4.21% |
| Cost of Revenue | 1.49% | -1.99% | -5.71% | -8.88% | -9.74% |
| Gross Profit | 3.11% | 8.26% | 9.07% | 8.66% | 16.22% |
| SG&A Expenses | 4.72% | 5.10% | 2.37% | 0.99% | 4.70% |
| Depreciation & Amortization | 3.06% | -2.90% | -17.01% | -32.27% | -32.97% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.97% | -1.03% | -4.80% | -8.01% | -8.38% |
| Operating Income | 1.48% | 13.01% | 20.68% | 25.81% | 42.45% |
| Income Before Tax | -0.36% | 59.73% | 380.22% | 313.57% | 174.64% |
| Income Tax Expenses | 27.07% | 62.16% | 3,999.30% | 2,346.65% | 313.28% |
| Earnings from Continuing Operations | -7.46% | 59.03% | 311.52% | 266.94% | 163.89% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.46% | 59.03% | 311.52% | 266.94% | 163.89% |
| EBIT | 1.48% | 13.01% | 20.68% | 25.81% | 42.45% |
| EBITDA | 1.62% | 11.41% | 16.12% | 17.14% | 29.41% |
| EPS Basic | -2.08% | 62.81% | 307.28% | 263.20% | 162.56% |
| Normalized Basic EPS | 10.87% | 24.96% | 34.40% | 43.15% | 64.18% |
| EPS Diluted | -3.12% | 62.18% | 303.41% | 261.10% | 161.92% |
| Normalized Diluted EPS | 9.36% | 23.83% | 33.47% | 42.37% | 63.36% |
| Average Basic Shares Outstanding | -5.01% | -2.64% | -0.63% | 0.90% | 1.88% |
| Average Diluted Shares Outstanding | -3.83% | -1.80% | 0.06% | 1.40% | 2.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |